The Biotechnology Center staff has gathered articles and other resources to help navigate through the myriad of funding issues.
- Bouchie, Aaron. "Private biotech companies face new funding challenges." Bioe News. (Bioentrepreneur website from Nature Publishing Group) Published online July 24, 2003. Free registration.
- Chea, Terence. "Biotech firms thwarted by bureaucracy; Industry seeks a liaison office to help navigate government's biodefense efforts." The Washington Post. Feb. 7, 2002.
- Chiruvolu, Ravi. Before you do that amazing biotech deal, read this story." Venture Capital Journal. Aug. 1, 2002.
- Crabtree, Penni. "Startups suffering a drought of dollars; While innovation continues, companies take fewer risks to maintain flow of venture capital." San Diego Union-Tribune. May 11, 2004.
- Dibner, Mark D. and Michael Howell. "Finding Funding in Biotechnology: Keeping the Companies Alive." BioPharm. June 2002.
- Directory of Biomedical and Health Care Grants, 2004. 18th edition. Oryx Press.
- Dooley, Joseph F. III and Joseph F. Dooley, Jr. Convincing a venture capitalist to invest in your idea." Bioentrepreneur, supplement to Nature Biotechnology. July 2003.
- Duca, John V., and Mine K. Yucel."An Overview of Science and Cents: Exploring the Economics of Biotechnology." Federal Reserve Bank of Dallas Economic and Financial Policy Review, Vol. 1, No. 3, 2002.
- Firstenberg, Paul B. Philanthropy's Challenge: Building Nonprofit Capacity Through Venture Grantmaking. The Foundation Center. 2003.
- Fleischer-Black, Matt. "Patient, heal thyself." Corporate Counsel. June 11, 2002.
- The Foundation Center's Guide to Grantseeking on the Web. The Foundation Center. 2003.
- Gaither, Chris. "NIH rule hits some biotech start-ups; Firms controlled by venture capitalists ineligible for grants." The Boston Globe. July 5, 2003.
- Gonzales, Angela. "Finding funding: Small biotech firms look to big pharma for cash." The Business Journal of Phoenix. June 11, 2004.
- Grimes, F. Randall. "Why grants are good for business: Government Research and Development funding can help a startup in more ways than one." Genome Technology. May 1, 2003. Registration required.
- Grimes, F. Randall. "Where to find funding opportunities: Cast a broad net to improve your chances of winning grants." Genome Technology. June 1, 2003. Registration required.
- Grimes, F. Randall. "Honing your grant writing strategy: Why a narrow approach is better than a scattershot one." Genome Technology. July 1, 2003. Registration required.
- Lawlor, Michael S."Biotechnology and Government Funding: Economic Motivation and Policy Models." Prepared for Science and Cents: The Economics of Biotechnology, Federal Reserve Bank of Dallas, April 19, 2002.
- Mitchell, Phyllis. "National Institutes of Health: Small Business Funding OpportuNIHtie$" Presentation on Government Funding Sources from BioEntrepreneur Symposium, May 11, 2002.
- Osborne, Randall. "Dramatic shift in VC, biotech talent pool from West to East." BioWorld Financial Watch. May 24, 2004.
- Park, Paula. "Taking a Discovery to Market." The Scientist. Registration required. Part 1, "Selling the Story of a Discovery," published on Nov. 12, 2001
Part 2, "Climbing the Money Tree," published on Nov. 26, 2001
Part 3, "Dealing in Relationships," published on Dec. 10, 2001 - Patalon III, William. "More willing sources of capital seen on horizon." The Baltimore Sun. Jan. 11, 2004.
- Purcell, Dennis J. "Financing Biotechnology in an Inefficient Market." Bioentrepreneur, supplement to Nature Biotechnology. May 1999.
- Salisbury, Meredith W. "Your Guide to Grants and Gurus." Genome Technology. May 1, 2004.
- Stone, Jim. "Finding the funding." AFP Exchange. May 1, 2002.
Van, Jon. "Terrorism fears fuel biotech funding; U.S. wants specific products in return." Chicago Tribune. March 28, 2004.
The Massachusetts Biotechnology Council hosted a session called "Venture Philanthropy: New Money for New Cures."
Organizers described the April 24, 2003, event by saying: "With traditional financing markets remaining weak, new development models have emerged from unlikely places to support innovation in the treatment of serious diseases. Foundations are moving from 'grantor' roles and venturing into 'investor' roles. Will this be a sustainable new source of capital formation for the biotech industry?"
Two PowerPoint presentations are available:
- Kim Hunter-Schaedle, PhD, Associate Director, Industry Relations, Juvenile Diabetes Research Foundation International.
- Lorenzo Refolo, PhD, Scientific Director, Institute for the Study of Aging.